Llwytho...
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
BACKGROUND AND AIM: Coronavirus disease 2019 (COVID‐19) has attracted increasing worldwide attention. While diabetes is known to aggravate COVID‐19 severity, it is not known whether nondiabetic patients with metabolic dysfunction are also more prone to more severe disease. The association of metabol...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Gastroenterol Hepatol |
|---|---|
| Prif Awduron: | , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280625/ https://ncbi.nlm.nih.gov/pubmed/32436622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.15112 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|